These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
468 related items for PubMed ID: 31405761
1. Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries. Mohapatra A, Saadeddin Z, Bertges DJ, Madigan MC, Al-Khoury GE, Makaroun MS, Eslami MH. J Vasc Surg; 2020 Feb; 71(2):560-566. PubMed ID: 31405761 [Abstract] [Full Text] [Related]
3. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J, Beschorner U, Schwarzwälder U, Schwarz T, Noory E. J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582 [Abstract] [Full Text] [Related]
4. Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease. Bausback Y, Wittig T, Schmidt A, Zeller T, Bosiers M, Peeters P, Brucks S, Lottes AE, Scheinert D, Steiner S. J Am Coll Cardiol; 2019 Feb 19; 73(6):667-679. PubMed ID: 30765033 [Abstract] [Full Text] [Related]
14. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions in intermittent claudication: A network meta-analysis of randomized controlled trials. Zhou Y, Wang J, He H, Li Q, Li M, Li X, Shu C. Int J Cardiol; 2021 Nov 15; 343():122-130. PubMed ID: 34461162 [Abstract] [Full Text] [Related]
15. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon). Schroeder H, Werner M, Meyer DR, Reimer P, Krüger K, Jaff MR, Brodmann M, ILLUMENATE EU RCT Investigators. Circulation; 2017 Jun 06; 135(23):2227-2236. PubMed ID: 28424223 [Abstract] [Full Text] [Related]
16. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis. Giannopoulos S, Kokkinidis DG, Jawaid O, Behan S, Hossain P, Alvandi B, Foley TR, Singh GD, Waldo SW, Armstrong EJ. Cardiovasc Revasc Med; 2020 Jun 06; 21(6):771-778. PubMed ID: 31761634 [Abstract] [Full Text] [Related]
19. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries. Sixt S, Carpio Cancino OG, Treszl A, Beschorner U, Macharzina R, Rastan A, Krankenberg H, Neumann FJ, Zeller T. J Vasc Surg; 2013 Sep 06; 58(3):682-6. PubMed ID: 23755977 [Abstract] [Full Text] [Related]
20. Comparing the impact of the loss of patency between treatment with drug-coated balloon angioplasty and drug-eluting stent placement. Nagatomi S, Takahara M, Nakai T, Fujimura N, Yu A, Matsuda D, Yamaoka T, Bolstad F, Yamamoto H, Ichihashi S. J Vasc Surg; 2023 Jun 06; 77(6):1751-1759. PubMed ID: 36796593 [Abstract] [Full Text] [Related] Page: [Next] [New Search]